There is also evidence that regulatory T lymphocytes (Tregs; CD4+CD25+FoxP3+) may modulate the severity of stroke outcome (Liesz et al., 2009), despite exerting acutely detrimental effects by promoting intravascular coagulation during reperfusion (Kleinschnitz et al., 2013). Here, CD4 is linked to stroke disorder.